Contributor: Rosa Garcia-Verdugo

Rosa García-VerdugoRosa Garcia-Verdugo studied Biochemistry at University of Oviedo and, after working for a while in immunology at the Center for Biological Research (CIB) and another brief period of systems biology at the Center for Genomic Regulation (CRG), she eventually got her PhD in systems neurobiology at the Max-Planck-Institute of Neurobiology in Munich. Her research deals with neuronal plasticity in mouse visual cortex and big 2-photon microscopes.

Coronavirus Covid-19 treatment illustration banner

Tocilizumab : a treatment alternative in COVID-19 pneumonia

Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Prof Cristina Mussini about covid-19 treatment

Interview with Professor Cristina Mussini, Head of the Department of Infectious Diseases and Tropical Medicine at the University of Modena and Reggio Emilia in Italy and member of the European AIDS Clinical Society. She has been actively involved in various recent studies on the clinical use of tocilizumab in patients with COVID-19 pneumonia. First a ...

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Dr Andrew Ip about covid-19 treatment

Interview with Dr Andrew Ip, a specialist in hematology/oncology at the John Theurer Cancer Center at Hackensack University Medical Center, USA, who has been involved in research on tocilizumab use in COVID-19 patients. Why did you choose tocilizumab to treat patients with COVID-19 pneumonia? Tocilizumab is a monoclonal antibody that inhibits the interleukin-6 (IL-6) receptor. ...

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Dr Juan Victor San-Martin Lopez about covid-19 treatment

Interview with Dr Juan Victor San-Martín López, a physician specialising in infectious diseases and a member of the task force coordinating responses to the leishmaniasis outbreak in 2011 and to COVID-19 at the Hospital Universitario de Fuenlabrada, Spain. He reports on his experience with tocilizumab use in COVID-19 patients. What is the so-called cytokine storm? ...

acrylic researcher who thinks of scientific experiments

A scientist’s opinion : Interview with Prof. Maria Baghramian about PEriTiA

Interview with Maria Baghramian, PEriTiA’s project coordinator Prof Maria Baghramian, MRIA (UCD) is Professor of American Philosophy in the School of Philosophy at University College Dublin and co-director of the Postgraduate Programme in Cognitive Science at UCD, which she co-founded in 2000. She has also held visiting posts at Harvard, MIT, University of Yerevan, Institut ...

acrylic researcher who thinks of scientific experiments

What drives public trust in science-based policies? Ask PEriTiA

A multinational EU research project will review the role of science in policy decision-making using climate change as a proxy with the aim of establishing public trust.

acrylic researcher who thinks of scientific experiments

A scientist’s opinion : Interview with Prof. Bobby Duffy about PEriTiA

Interview with Bobby Duffy, leader of PEriTiA’s data collection and analysis team Prof Bobby Duffy, Director of The Policy Institute at King's College London, leads the PERITIA’s data collection and analysis. His responsibility is to ensure the integrity of survey design and analytical approach. He has spent much of his career studying levels and drivers of individual ...

acrylic researcher who thinks of scientific experiments

A scientist’s opinion : Interview with Prof. José van Dijck about PEriTiA

Interview with José van Dijck, leading PEriTiA’s analysis on media impact on trust Prof José van Dijck, MR, is a distinguished university professor at the University of Utrecht and a prolific author on the topic of digital media and its impact. Her work covers a wide range of topics in media theory, media technologies, social ...